A new paradigm for the treatment of Alzheimer's disease: targeting vascular activation. [electronic resource]
Producer: 20141217Description: 619-30 p. digitalISSN:- 1875-8908
- Alzheimer Disease -- drug therapy
- Amyloid beta-Protein Precursor -- genetics
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Antifibrinolytic Agents -- pharmacology
- Avoidance Learning -- drug effects
- Blood Vessels -- drug effects
- Brain -- drug effects
- Endothelial Cells -- drug effects
- Humans
- Indoles -- pharmacology
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Motor Activity -- drug effects
- Presenilin-1 -- genetics
- Pyrroles -- pharmacology
- Reaction Time -- drug effects
- Sunitinib
- Time Factors
- Vitamin K 3 -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.